SCHEMBL6963164

SCHEMBL6963164

OCC(Cc1ccccc1)NC(=S)Nc1nccs1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
MAPK1 P28482 3/20 0.56
PKM P14618 2/20 0.56
KMT2A Q03164 2/20 0.56
LMNA P02545 2/20 0.56
ALDH1A1 P00352 2/20 0.56
GAA P10253 2/20 0.56
NFKB1 P19838 2/20 0.56
HTT P42858 2/20 0.56
CYP3A4 P08684 2/20 0.56
MEN1 O00255 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
THPO P40225 1/20 0.56
MTOR P42345 1/20 0.56
BLM P54132 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8687284 0.85 RAB9A (0.58) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6960139 0.81 HSPA1A (0.60) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6960135 0.81 HSPA1A (0.60) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6958345 0.79 LMNA (0.51) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6952333 0.78 PKM (0.57) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6952330 0.78 PKM (0.57) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL1520344 0.76 SMN1; SMN2 (0.71) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL5455503 0.76 KDM4E (0.70) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6959149 0.74 SMN1; SMN2 (0.61) NPC1RAB9ASMN1; SMN2MAPK1PKM
SCHEMBL6284442 0.73 NPC1 (0.57) NPC1RAB9ASMN1; SMN2MAPK1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0540143-B1 Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 2003-02-05 EP disclosed
US-5714503-A Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 1998-02-03 US disclosed
US-5593993-A VIRICIDES FOR HTLV TREATMENT OF AIDS MEDIVIR AB (SE) 1997-01-14 US disclosed
EP-0540143-A2 Compounds and methods for inhibition of HIV and related viruses Medivir Aktiebolag (SE) 1993-05-05 EP disclosed
WO-1993003022-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1993-02-18 WO disclosed